MAR 16, 2020 9:54 PM PDT

Critical Interleukin Leads to Drug Discovery

WRITTEN BY: Nouran Amin

The immune molecule interleukin-2 (IL-2) is a growth factor that stimulates the immune system to produce T-cells. Their powerful effects have encouraged researchers to harness them for therpeutic purposes.

"IL-2 can act as either a throttle or a brake on the immune response in different contexts," said Nikolaos Sgourakis, assistant professor of chemistry and biochemistry at UC Santa Cruz. "Our investigation used detailed biophysical methods to show how it does this."

Now, a study published in the Proceedings of the National Academy of Sciences discusses how nuclear magnetic resonance spectroscopy (NMR) was used to observe the structure of IL-2.

"We can use this information to tweak the balance, depending on what we want to achieve in a clinical setting," Sgourakis said. "To target regulatory T cells, we would want to stabilize the minor conformation, and to target effector T cells, we would want to stabilize the major conformation."

Learn more about interleukins:

"We have now come one step closer to a detailed understanding of how the IL-2 cytokine works," says visiting scientists and first author, Viviane De Paula. "It is the first time that anyone has managed to observe a transient state of IL-2 directly. With the use of NMR, we were able to describe the structure, dynamics, and function of IL-2 in its two conformations."

How does the study advance drug discovery? Well, for one, researchers discuss the numerous possibilities for drug development that can stabilize IL-2 for therapeutic applications.

"The details of the mechanism we present offer a direct blueprint for drug discovery," said corresponding author Christopher Garcia. "Every drug company wants to know how to engineer this cytokine, and this paper provides some of the first really bona fide structural clarity on the fascinating topic of IL-2 dynamics."

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
JAN 27, 2021
Drug Discovery & Development
Researchers Discover How LSD Encourages Prosocial Behavior
JAN 27, 2021
Researchers Discover How LSD Encourages Prosocial Behavior
Researchers from McGill University have discovered one of the possible mechanisms by which lysergic acid diethylamide (L ...
FEB 02, 2021
Genetics & Genomics
Using Genetic Tools to Find Treatment Options for PTSD
FEB 02, 2021
Using Genetic Tools to Find Treatment Options for PTSD
With genome-wide association studies, researchers have been able to link small variations in the genome to a greater (or ...
MAR 24, 2021
Drug Discovery & Development
Three Compounds May Be Suitable for SARS-CoV-2
MAR 24, 2021
Three Compounds May Be Suitable for SARS-CoV-2
Researchers have found that that three common antiviral and antimalarial therapeutics may be effective in vitro at targe ...
APR 01, 2021
Drug Discovery & Development
Injection Treats Childhood Blindness
APR 01, 2021
Injection Treats Childhood Blindness
A patient with a genetic-based childhood blindness has gained vision after receiving an experimental RNA therapeutic tre ...
APR 14, 2021
Cancer
Cell Viability- Where to Begin?
APR 14, 2021
Cell Viability- Where to Begin?
Written By: Author As I pondered the title of this article, my thoughts immediately went back to a request by my Ph.D. a ...
APR 24, 2021
Drug Discovery & Development
Lithium Treats Intellectual Disabilities in Mice
APR 24, 2021
Lithium Treats Intellectual Disabilities in Mice
Mouse models of Bardet-Biedl Syndrome (BBS) have a challenge with learning as a result of dysfunctional neuronal systems ...
Loading Comments...